Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Reg. 34 (1) Annual Report

We wish to inform you that the 41st Annual General Meeting ('AGM') of the Company shall be held on Wednesday,September 25, 2019 at 11.30 a.m. at the Registered Office at Bhartiagram, Gajraula, District Amroha - 244 223, U.P. We enclose Annual Report for the Financial Year 2018-19 and a copy of the Notice of the 41st AGM, being dispatched to the shareholders of the Company. In terms of Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 91 of the Companies Act, 2013 including rules made thereunder, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, September 14, 2019 to Wednesday, September 25, 2019 (both days inclusive). The Dividend on equity shares @ Rs. 4.50 per equity share of Re. 1 each, if declared at the AGM, will be paid on or before Thursday, October 24, 2019
31-08-2019
Bigul

Jubilant Life Sciences poised at long-term base

A break above 500 will alter the short-term downtrend and take the stock up to 600
18-08-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued duplicate share certificate to the following member as per the details attached. This is for your information and record.
17-08-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund Ltd
13-08-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Intimation Pursuant To Regulation 50(1) And 60(2) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Record Date And Interest Payment On Non-Convertible Debentures

We wish to inform you that payment of interest shall be made to the holders of Non-Convertible Debentures as per the attached details. Record date for the payment of interest stated above shall be August 21, 2019. This is for your information and records.
08-08-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Issuance Of Commercial Papers Of Rs. 40 Crore

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 40 Crore on August 2, 2019. Details of the same are enclosed. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs. 40 Crore. This is for your information and records.
02-08-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Intimation Pursuant To Regulation 57(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Payment Of Interest On Non-Convertible Debentures

Dear Sirs, This is to certify that the Company has duly made the payment of half yearly interest on Non- Convertible Debentures issued on private placement basis on due date as per the details attached. This is for your information and records.
29-07-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In continuation of our letter dated July 26, 2019, we enclose the copies of the Unaudited Consolidated Financial Results for the quarter ended June 30, 2019 published on July 27, 2019 in MINT (English) and HINDUSTAN (Hindi). This is for information and records.
29-07-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Evaluate Options To Create Focused Entities For JLL Businesses

The board of directors of the Company ('Board') at its meeting held on July 26, 2019 considered the option of reorganizing its businesses with the following objectives: (a) create separate and focused entities for Pharmaceuticals and Life Science Ingredients businesses to manage different risks, rewards and regulatory requirements; (b) enable strategic growth for these businesses with optimal capital structure; (c) potentially unlock shareholder value with direct ownership in each of the business entities. The Board has constituted a Committee to evaluate various options including reorganisation / demerger of business undertakings on a going concern basis and provide its recommendations. Any decision in this regard will be after due evaluation and consideration by the Board and be subject to all necessary consents and approvals. The Company will at the relevant time take necessary steps to comply with all applicable laws and regulations including the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for information and record.
26-07-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Results For Quarter Ended June 30, 2019

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2019 were approved by the Board of Directors of the Company at its meeting held today at 1.00 p.m. and concluded at 2.45 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2019; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and 3. Copies of the Press Release and Presentation. We request you to take the same on records.
26-07-2019
Next Page
Close

Let's Open Free Demat Account